Medical/Pharmaceuticals
Atonarp announces innovative new metrology platform Aston, aimed at increasing yield, throughput, and efficiency in semiconductor manufacturing processes
TOKYO, July 15, 2021 /PRNewswire/ -- Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the semiconductor, healthcare, and pharma industries, today announcedAston, an innovative in-situ semiconductor metrology platform with an integrated plasma ionization source. ...
2021-07-15 21:15
2777
ELITechGroup Acquires GONOTEC, A Leading Market Player In Freezing Point Osmometry
LOGAN, Utah, July 15, 2021 /PRNewswire/ -- ELITechGroup, market leader in global vapor pressure osmometer technology, announces the acquisition of GONOTEC, a leading market player in freezing point osmometer technology. The purchase of the company unites two osmometry market leaders, providing t...
2021-07-15 20:00
2383
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 22 at 9:30 CEST
STOCKHOLM, July 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOElisabet Lund. To register for the presentation of the ...
2021-07-15 16:20
1262
Cigna International finds community spirit and duty to society top driver of COVID-19 vaccine uptake
Key research findings: * Vaccine acceptance continues to improve – steady increase in vaccine acceptance, 69% up from 63% in three months * Urgency has increased – those waiting to get a vaccination until more people have had their first one dropped 8% in three months, from 50% to 42% * Vac...
2021-07-15 15:30
45282
Transcenta Announces First Patient Dosed in Global Phase I Clinical Trial of PD-L1/TGF-β Bi-functional Antibody TST005
SUZHOU, China, July 15, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces that the first US patient has been dosed...
2021-07-15 11:23
1938
Ascentage Pharma and Innovent Biologics Reach Multifaceted Strategic Agreement Totaling US$245 Million Including Commercialization of Olverembatinib (HQP1351) in China, Joint Clinical Development of Lisaftoclax (APG-2575) and Equity Investment
SUZHOU, China, and ROCKVILLE, Md., July 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics (1801.HK, "Innovent"), today an...
2021-07-15 01:43
5239
Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment
SAN FRANCISCO and SUZHOU, China, July 14, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-14 23:48
15431
Frost & Sullivan Best Practices Recognition Honors Industry-leading Companies at the 2021 Asia-Pacific Virtual Awards Ceremony
Sixteen companies recognized for their exemplary performance and valuable contributions in shaping new trends acrossAsia-Pacific SINGAPORE, July 14, 2021 /PRNewswire/ -- Frost & Sullivan honored leading companies in the region at the 19th annual Asia-Pacific Best Practices Awards on 14 July. At ...
2021-07-14 18:28
1580
Antengene Submits New Drug Application for Selinexor in Taiwan for the Treatment of Three Indications in Hematologic Malignancies
SHANGHAI and HONG KONG, July 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...
2021-07-14 10:00
21190
UK - National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on 'Trublood®- Prostate' for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer'
LONDON, July 14, 2021 /PRNewswire/ -- Datar Cancer Genetics, a world leading non-invasive cancer analytics and diagnostics company having its Research Head Quarters at Nasik,India, announced the publication of the internationally recognized MedTech Innovation Briefing (MIB) from theUnited Kingdom...
2021-07-14 07:00
7186
ZEISS Introduces the Fully Integrated, Data-Driven Medical Ecosystem
JENA, Germany and DUBLIN, Calif., July 13, 2021 /PRNewswire/ -- ZEISS today announced its newZEISS Medical Ecosystem, a fully integrated environment where a combination of devices, data management, applications and services drive continuous improvement of patient outcomes. This ecosystem distinct...
2021-07-13 22:00
1953
Envision Donates Covid-19 Medical Equipment to India
SHANGHAI, July 13, 2021 /PRNewswire/ -- Envision Group, a world-leading green technology company, recently donated dozens of oxygen concentrators and 44,000 protective masks toIndia in wake of the shortage of essential medical supplies during the second wave of the Covid-19 pandemic. Mahara...
2021-07-13 21:19
1873
Global consulting firm Star acquires Pro4People, creating powerhouse in MedTech development and regulatory consulting
WROCLAW, Poland, July 13, 2021 /PRNewswire/ -- Star, a global technology company connecting end-to-end strategy, design and engineering services, announced its acquisition of Pro4People, a leading software consultancy based in Wroclaw,Poland, specializing in regulated MedTech and Digital Healthca...
2021-07-13 20:59
1653
Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus
* Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. * The new CE-IVD marked variants detection kit to differentiate 10 major COVID-19 variants including the...
2021-07-13 20:00
1370
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China
SHANGHAI, July 13, 2021 /PRNewswire/ -- Everest Medicines
2021-07-13 19:47
5539
Ascletis Announces Dosing of the First Cohort of Healthy Subjects in the FXR Agonist ASC42 Bridging Study for Chronic Hepatitis B Indication in China
--This bridging study to select doses for the Phase II trial in China in patients with chronic hepatitis B (CHB) --ASC42 clinical trials are being conducted in the U.S. and China for non-alcoholic steatohepatitis (NASH) and CHB. HANGZHOU and SHAOXING, China, July 13, 2021 /PRNewswire/ -- A...
2021-07-13 08:30
2404
Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
PARIS, July 12, 2021 /PRNewswire/ -- Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced todaythat they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological ...
2021-07-12 23:00
1379
Werfen Companies Unite Under One Name And One Brand
BARCELONA, Spain, July 12, 2021 /PRNewswire/ -- Werfen today announced that its companies, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, are uniting under one name and one brand—Werfen. As part of this effort, the Company has completed organizational transition...
2021-07-12 20:00
1521
ProfoundBio Announces Completion of More Than $55 million Series A Financing to Advance Novel Antibody-Drug Conjugate (ADC) Portfolio
WOODINVILLE, Wash. and SUZHOU, China, July 12, 2021 /PRNewswire/ -- ProfoundBio announced the closing of a $55+ million Series A financing round led byLilly Asia Venture and co-led by LYFE Capital, with participation from Sequoia Capital China and Oriza. All investors from the Series Pre-A finan...
2021-07-12 17:00
2052
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies
HOUSTON and SINGAPORE, July 12, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce major improvements in treatment outcomes, andThe University of Texas MD Anderson Cancer Ce...
2021-07-12 17:00
1295
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7862
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6955
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4242
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2819